Results 11 to 20 of about 1,546,198 (186)
Burkholderia cepacia is almost always a colonizing organism rather than an infecting organism, but it may be pathogenic in immunocompromised individuals when isolated from body fluids that are ordinarily sterile.
Vijoy Kumar Jha +3 more
doaj +4 more sources
The article presents a clinical case of development cepacia syndrome in a patient with cystic fibrosis and the detailed 4-month therapy, which is repeatedly adjusted depending on the condition of the patient.
D F Sergienko +3 more
doaj +2 more sources
Burkholderia cepacia meningitis in the Central African Republic [PDF]
Burkholderia cepacia causes frequent infections in immunocompromised and hospitalized patients, with a significant mortality rate. This bacterial species has also been associated with epidemic outbreaks due to contamination of antiseptic solutions and ...
Thierry Frank +7 more
doaj +2 more sources
The Burkholderia cepacia complex (Bcc) comprises a group of genetically related yet phenotypically diverse Gram-negative opportunistic pathogens. These organisms demonstrate significant pathogenicity in immunocompromised populations, particularly cystic ...
CUI Wenjie, LU Rongqi, LIU Yali
doaj +2 more sources
Management of Cepacia Syndrome With a Combination of Intravenous and Inhaled Antimicrobials in a Non-Cystic Fibrosis Pediatric Patient. [PDF]
Burkholderia cepacia complex (Bcc) is an opportunistic pathogen, posing little risk to healthy individuals. The presentation of Bcc can vary from a virtually asymptomatic chronic infection, to an acute, life-threatening necrotizing pneumonia, acute respiratory distress syndrome, and bacteremia (cepacia syndrome) associated with a mortality ...
Branstetter JW, Yarbrough A, Poole C.
europepmc +4 more sources
A Case Report of Necrotizing Pneumonia Due to Burkholderia cepacia Syndrome. [PDF]
Burkholderia cepacia (B. cepacia) complex is a highly resistant gram-negative pathogen known to cause lung infection in cystic fibrosis, chronic granulomatous disease, and immunocompromised patients. However, it may rarely infect immunocompetent patients as well.
Hedary AS, DeBord NL, Marshall D.
europepmc +3 more sources
Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited. [PDF]
X-linked carriers of chronic granulomatous disease (CGD) may become phenotypically affected if substantial skewing from lyonisation occurs. We describe a 73-year-old female carrier with an overt CGD phenotype due to skewed lyonisation, complicated by macrophage activation syndrome (MAS)/haemophagocytic lymphohistiocytosis (HLH) secondary to ...
Urriola N, Williams A, Keat K.
europepmc +4 more sources
Chronic granulomatous disease (GCD) is characterized by severe infections, notably with Burkholderia cepacia complex (BCC). GCD is rarely complicated by lymphohistiocytic activation syndromes, most often secondary to bacterial or viral infections, in particular human herpes virus 6 (HHV-6).
A. Araujo +6 more
openaire +2 more sources
Genomic Insights into a New Burkholderia cenocepacia Sequence Type Linked to Cepacia Syndrome in Cystic Fibrosis. [PDF]
Abstract Burkholderia cenocepacia is an important pathogen in cystic fibrosis (CF) patients, responsible for chronic lung infections and, in severe cases, cepacia syndrome (CS), characterized by necrotizing pneumonia, bacteremia, and high mortality. Epidemic lineages, such as
Xavier TS +8 more
europepmc +3 more sources

